NERELIMOMAB
UNII 1911H0X9KJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Nerelimomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1911H0X9KJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 162774-06-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1911H0X9KJ

CAS Registry Number

162774-06-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NERELIMOMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166480

National Cancer Institute reference terminology for clinical and research data.

INN ID

7546

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HH-67

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nerelimomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NERELIMOMAB

Common Names & Synonyms

NERELIMOMAB [INN]

NERELIMOMAB [USAN]

NERELIMOMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR .ALPHA.) (MOUSE MONOCLONAL BAYX1351 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL BAYX1351 LIGHT CHAIN, DIMER )

SYS